A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation.
Nishizawa. Naoki N; Asami. Taiji T; Nishibori. Kimiko K; Takatsu. Yoshihiro Y; Suzuki. Atsuko A; Ushio. Kazutaka K; Matsumoto. Shin-Ichi SI; Shimizu. Yuji Y; Yamaguchi. Masashi M; Kusaka. Masami M; Matsui. Hisanori H; Ohtaki. Tetsuya T; Kitada. Chieko C
Key Findings
- A pentapeptide (five‑amino‑acid) kisspeptin analog (compound 16) is a strong KISS1R agonist and is stable in rat serum.
- A single injection of a related analog (compound 19) sharply raises LH levels in male rats.
- Continuous dosing of compound 19 maintains moderate testosterone levels, avoiding the depletion seen with longer kisspeptin analogs.
Practical Outcomes
- For biohackers, this research hints that very short, stable kisspeptin peptides could become oral or injectable tools to modulate LH and testosterone more gently than existing longer peptides. However, the data are limited to rats, so human dosing, safety, and effectiveness are still unknown. Until human trials are done, the findings are mainly of interest for future drug development rather than immediate self‑experimentation.
Summary
Scientists made a tiny version of the kisspeptin hormone (just five amino acids) that can still turn on the brain's reproductive hormone system. In male rats, a single dose boosted luteinizing hormone (LH) and, when given continuously, kept testosterone at a steady, moderate level instead of the big spikes or drops seen with longer kisspeptin peptides. This shows that very small, stable peptide drugs might be used to fine‑tune sex hormones.
Abstract
The kisspeptin (Kp, Kp-54, metastin)/KISS1R system plays crucial roles in regulating the secretion of gonadotropin-releasing hormone. Continuous administration of nonapeptide Kp analogs caused plasma testosterone depletion, whereas bolus administration caused strong plasma testosterone elevation in male rats. To develop a new class of small peptide drugs, we focused on stepwise N-terminal truncation of Kp analogs and discovered potent pentapeptide analogs. Benzoyl-Phe-azaGly-Leu-Arg(Me)-Trp-NH<sub>2</sub> (16) exhibited high agonist activity for KISS1R and excellent metabolic stability in rat serum. A single injection of a 4-pyridyl analog (19) at the N-terminus of 16 into male Sprague Dawley rats caused a robust increase in plasma luteinizing hormone levels, but unlike continuous administration of nonapeptide Kp analogs, continuous administration of 19 maintained moderate testosterone levels in rats. These results indicated that small peptide drugs can be successfully developed for treating sex hormone deficiency.
Study Information
pubmed
2018
2018-12-10T00:00:00.000Z
10.1016/j.bmcl.2018.12.016
4
25